Lineage Cell Therapeutics, Inc. Common Stock (LCTX) CapEx to Depreciation & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · CapEx to Depreciation

LCTX CapEx to Depreciation

Current (TTM)0.17×retrievedOct 20, 2026

LCTX CapEx/Depreciation (0.00× → 0.17×)

Latest values, visible window

High-resolution chart · PNG

LCTX capex to depreciation history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock CapEx to Depreciation — Annual fiscal periods
Period ending	CapEx to Depreciation
Dec 31, 2025	0.7468×
Dec 31, 2024	0.9278×
Dec 31, 2023	0.974×
Dec 31, 2022	0.5681×
Dec 31, 2021	0.4055×
Dec 31, 2020	0.0314×
Dec 31, 2019	0.1467×
Dec 31, 2018	1.0043×
Dec 31, 2017	0.4023×
Dec 31, 2016	0.531×
Dec 31, 2015	0.8421×
Dec 31, 2014	0.0574×
Dec 31, 2013	0.5761×
Dec 31, 2012	0.1415×
Dec 31, 2011	0.4064×
Dec 31, 2010	0.4692×
Dec 31, 2009	1.7714×
Dec 31, 2008	51.351×
Dec 31, 2007	-0.0342×
Dec 31, 2006	0.4022×
Dec 31, 2005	0×
Dec 31, 2004	0×
Dec 31, 2003	0×
Dec 31, 2002	0.0076×
Dec 31, 2001	0.0173×
Dec 31, 2000	0.4427×
Dec 31, 1999	2.7161×
Dec 31, 1998	0×
Jun 30, 1998	0×
Jun 30, 1996	0×
Jun 30, 1995	0×
Jun 30, 1994	0×
Jun 30, 1993	0×
Jun 30, 1992	0×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.